HXN-2003

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameHXN-2003
Drug Alias NameHXN-2003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Cadherin-17Anti-CEACAM5
TargetsCadherin-17Carcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesEarendil Labs
China Registration ClassN/A

Develop Information

Active CompaniesEarendil Labs
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A